Browsing Tag
Aurolife Pharma
1 post
Aurobindo Pharma wins first US metered-dose inhaler approval in $301m asthma market
Aurobindo Pharma has received final USFDA approval for its first metered-dose inhaler, a beclomethasone HFA generic addressing an estimated $301 million US market and validating a respiratory-development effort that has taken several years to reach commercial approval.
September 16, 2026